[Edaily Starin YUN GI BACK Reporter] The group SF9 is stepping up preparations for their comeback by unveiling the promotional schedule for their second full-length album, “TENACITY.” This album, which encapsulates the group’s nearly 10 years of activity, is generating high expectations as a work that heralds a new leap forward for the group. (Photo courtesy of FNC Entertainment) Their agency, FNC Entertainment, unveiled the “TENACITY” promotional schedule poster via its official social media channels on the 7th. Featuring a giant black bird as its motif, the poster details the schedule for various teaser content to be released ahead of the album’s launch, heightening anticipation for the new album. Starting on the 10th, SF9 plans to gradually build anticipation for their comeback by sequentially unveiling the tracklist, listening guide, trailer film, music video teaser, and album sampler. On the 26th, the album’s release date, they will hold a showcase to share their new songs with fans for the first time. The album title, “Tersa3ty,” embodies the meaning of “perseverance and indomitable will” while incorporating “TEN,” which symbolizes their 10th debut anniversary. Through this album, SF9 plans to reflect on their journey over the past decade while delivering a message heralding a new leap forward. The 10th-anniversary celebrations will continue even after the comeback. SF9 plans to spend meaningful time with fans through various events, including a pop-up store, a live stream on their debut anniversary, and a concert in Seoul.
Kim Chang-soo, former president of Chung-Ang University, has taken office as the 21st chairman of the Private School Teachers’ Pension Fund (PSTPF) and has officially begun his duties. Having inherite…
With the deadline for stricter environmental regulations in the European automotive market just two months away, domestic cybersecurity companies are stepping up their efforts. This is because, starti…
Dr. Pooja Dua of Olix Pharmaceuticals, Inc.’s U.S. subsidiary, Olix US (Photo courtesy of the Drug Information Association (DIA))
Olix Pharmaceuticals, Inc.(226950)announced the development progre…